Knowledge * Excellence * Guidelines

Guidelines are key to modern health and medical practice. Their recommendations are evidence-based and cover a wide range of topics - managing specific conditions, use of medicines in different settings or services and interventions to improve health. 

NICE has accredited the process used by British Society for Rheumatology to produce its clinical guidance. 

Accreditation is valid for five years from February 2013. 

For full details on our accreditation visit nice.org.uk/accreditation 

View the current Protocol we follow when developing our guidelines.

 

Current guidelinesProducedDue for revision
2017
NICE Accredited

2020
2017
NICE Accredited

2020
2017
NICE Accredited

2020
2016
NICE Accredited

2019
2016
NICE Accredited

2019
2016
NICE Accredited

2019
2016
NICE Accredited

2019
2013
NICE Accredited

2017
Guideline for the treatment of psoriatic arthritis with biologics - Full guideline

Guideline for the treatment of psoriatic arthritis with biologics - Full guideline

June 2016: This guideline was due for revision.  After discussion with members of the Working Group who created it, it has been decided that a review of the guideline should be postponed until 2017.

Documents to download

2013
NICE Accredited

2017
Guideline for management of the hot swollen joint in adults - Full guideline

Guideline for management of the hot swollen joint in adults - Full guideline

The guideline for the management of the hot swollen joint was first published in 2006. Although there is not enough data to constitute a change in the guideline, there is sufficient new information to warrant an update within the next two years. Read the accompanying statement for more detail. March 2017

Documents to download

2006
Renewed and accepted unchanged in 2012. Reviewed again in 2017. An update of the guideline will be due within the next two years.

2019
2009

2018
Guidelines under revisionDue for publication
mid to late 2017
Will become part of GL above
2016
New guidelines in developmentDue for publication
Q2 2017
TBC
TBC